Munish Goyal, MD, FACEP, is the Director of Emergency Intensive Care in the Department of Emergency Medicine at MedStar Washington Hospital Center (MWHC). In addition, he is an Associate Professor of Emergency Medicine at the Georgetown University School of Medicine. His previous experience includes work in the surgical intensive-care unit and emergency department at the Hospital of the University of Pennsylvania.
As an Emergency Physician trained in critical care, Dr. Goyal focuses on the downstream impact of early interventions. He is primarily interested in the care of critically ill and injured patients in the emergency department and has investigated the role of biomarkers and triage vital signs in identification of ischemia and severity of illness, the impact of time to antimicrobials in severe sepsis and septic shock, and the use of lactate in differing populations.
Dr. Goyal has published more than 50 manuscripts, reviews, and book chapters and currently is a site principal investigator of the Protocolized Care in Early Septic Shock (ProCESS) study and the Platelet-Oriented Inhibition in New TIA (transient ischemic attack) and Minor Ischemic Stroke (POINT) trial. He is a member of the steering committee of the Penn Alliance for Therapeutic Hypothermia national cardiac-arrest database.
Dr. Goyal has received numerous awards and recognition for his work and leadership. In addition to the Hero award from the R. Adams Cowley Shock/Trauma Center, he has been selected as Teacher of the Year, Mentor of the Year, and Faculty of the Year. Along with his clinical and research duties, Dr. Goyal is Associate Program Director of the MedStar Georgetown University Hospital/MWHC Pulmonary and Emergency Medicine Critical Care Fellowships and serves on the MWHC committees on critical care and sepsis. He is a Fellow of the American College of Emergency Physicians.
His medical degree is from the Medical College of Virginia/Virginia Commonwealth University School of Medicine in Richmond. After his residency in Emergency Medicine at Christiana Care Health System in Newark, DE, Dr. Goyal completed a fellowship in Trauma and Critical Care at the R. Adams Cowley Shock Trauma Center at the University of Maryland.
Dr. Goyal's research interests include
- Emergency medicine and care
- Critical care
- Healthcare-acquired infections (HAI)
- Septic shock
- Therapeutic hypothermia
Protocolized Care in Early Septic Shock (ProCESS)
Dr. Goyal is a site principal investigator on the ProCESS study. This 5-year, multicenter study of alternative resuscitation strategies for septic shock is funded by the National Institute of General Medical Sciences. Dr. Goyal's team currently has the fifth highest enrollment rate of the 26 sites in this study.
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Dr. Goyal is a site principal investigator of the POINT trial. The primary objective of this trial is to determine whether clopidogrel is more effective than placebo in preventing major ischemic vascular events when initiated within 12 hours of a transient ischemic attack.
- Research Areas
- Critical Care/Emergency Medicine